finviz.com and postreams.com are both overseas Marketing and are often compared head-to-head. This page lines them up item by item — rating, price, China accessibility, HQ, payments and refund policy — and ends with practical "which to pick" guidance.
On balance, finviz.com comes out slightly ahead — it offers Higher overall rating (9.0 vs 7.0). That said, postreams.com has its strengths too: Better mainland China accessibility. If that matters more to you, postreams.com is well worth considering.
| Comparison | finviz.com | postreams.com |
|---|---|---|
| Category | 📈 Marketing Stock Screener |
📈 Marketing AI社媒代运营 |
| Overall rating | 9.0/10 | 7.0/10 |
| Monthly price | N/A | N/A |
| Yearly price | — | — |
| China access | ★☆☆ Partial (proxy needed) |
★★☆ Mostly works |
| HQ | United States | Unknown |
| Network | — | — |
| Payment methods | — | — |
| Refund guarantee | — | — |
| Editor notes | 强大美股筛选器,有付费版,支持联盟计划 |
小企业自动生成并发布月度社媒内容。 |
| Data source | In-depth review | In-depth review |
The guidance above is auto-compiled by TG4G from public data and is not purchase advice. Always rely on the official site and your own testing. A green cell marks the better value on that dimension (higher rating / CN / refund, or lower price). Some links are affiliate links (rel="sponsored nofollow").
If you want all-round balance and reputation, choose finviz.com; if your core need happens to be postreams.com's strength (Better mainland China accessibility), then postreams.com is the better fit. Either way, trial the cheapest plan for a week before committing long-term.
This page is a side-by-side reference, not purchase advice; prices and policies are per the official sites, and some links are affiliate.